Information:
Fel:
ID
43210
Beskrivning
ODM derived from http://clinicaltrials.gov/ct2/show/NCT00334295?term=NCT00334295&rank=1
Länk
http://clinicaltrials.gov/ct2/show/NCT00334295?term=NCT00334295&rank=1
Nyckelord
Versioner (4)
- 2012-02-16 2012-02-16 -
- 2014-04-13 2014-04-13 - Julian Varghese
- 2014-08-10 2014-08-10 - Martin Dugas
- 2021-09-20 2021-09-20 -
Uppladdad den
20 september 2021
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility NCT00334295 Metastatic Endometrial Carcinoma
Similar models
Eligibility
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age
Item
18 Years and older
boolean
C0001779 (UMLS CUI-1)
Female
Item
Female Gender
boolean
C0086287 (UMLS CUI-1)
Metastatic endometrial carcinoma
Item
Histologically confirmed, recurrent or metastatic endometrial carcinoma
boolean
C0813148 (UMLS CUI-1)
Postmenopausal
Item
Postmenopausal
boolean
C0232970 (UMLS CUI-1)
Hormonreceptor positive tumor
Item
Hormonreceptor positive tumor
boolean
C1563119 (UMLS CUI-1)
Pre-treatment with Fulvestrant
Item
Pre-treatment with Fulvestrant
boolean
C1550147 (UMLS CUI-1)
Previous endocrine therapy
Item
Previous endocrine therapy of the endometrial carcinoma
boolean
C0262926 (UMLS CUI-1)
C0279025 (UMLS CUI-2)
C0279025 (UMLS CUI-2)
Previous malignancy
Item
Previous malignancy less than 3 years ago other than in situ carcinoma of the cervix, basal cell carcinoma or squamous carcinoma of the skin
boolean
C0262926 (UMLS CUI-1)
C0006826 (UMLS CUI-2)
C0006826 (UMLS CUI-2)